• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Frequently Used Guidance Documents


ODEIII specific guidances


Regulatory guidances


Electronic Submissions Guidances


Safety Guidances


Labeling Guidances


Other, specific therapeutics, products Guidances


Return to the Office of Drug Evaluation III (ODEIII) page